Article

HHS distributing $560 million to physicians impacted by COVID-19 pandemic

Author(s):

According to the U.S. Department of Health and Human Services, nearly $19 billion in total aid has been distributed to providers since November.

The U.S. Department of Health and Human Services (HHS) last week began making more than $560 million in Provider Relief Fund (PRF) Phase 4 General Distribution payments to more than 4,100 providers across the country.

In a news release, HHS noted that nearly $11.5 billion in PRF Phase 4 payments has been distributed to more than 78,000 providers in all 50 states, Washington D.C., and five territories. This distribution is in addition to American Rescue Plan Rural payments totaling nearly $7.5 billion in funding to more than 44,000 providers since November 2021.

Provider Relief Fund payments have been instrumental in helping health care providers prevent, prepare for, and respond to the coronavirus. Providers have used the funds to remain in operation and to continue supporting patient care. Health care organizations that are facing workforce shortages and staff burnout also are able to use these funds to support their recruitment and retention efforts.

“Provider Relief Funds have been a lifeline for health care providers across the country,” said Health and Human Services Secretary Xavier Becerra in a statement. “From providing life-saving care to tackling workforce challenges, these funds will help many health care facilities weather the pandemic’s continued impact.”

Phase 4 payments have an increased focus on equity, including reimbursing a higher percentage of losses for smaller providers and incorporating bonus payments for providers who serve Medicaid, Children's Health Insurance Program, and Medicare beneficiaries. Approximately 86 percent of all Phase 4 applications have now been processed. Remaining applications will continue to be processed throughout early 2022.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.